Non-uniform response to temozolomide therapy in a pituitary gonadotroph adenoma.
Ayca
A
Ersen
Luis V
LV
Syro
Luis
L
Penagos
Humberto
H
Uribe
Bernd W
BW
Scheithauer
Leon D
LD
Ortiz
Fabio
F
Rotondo
Eva
E
Horvath
Kalman
K
Kovacs
D000236:Adenoma / Q000188:drug therapy*; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D015254:DNA Modification Methylases / Q000378:metabolism; D045643:DNA Repair Enzymes / Q000378:metabolism; D003606:Dacarbazine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D052681:Gonadotrophs / Q000187:drug effects / Q000473:pathology*; D006801:Humans; D019394:Ki-67 Antigen / Q000378:metabolism; D007986:Luteinizing Hormone / Q000378:metabolism; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D010902:Pituitary Gland / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D010911:Pituitary Neoplasms / Q000188:drug therapy*; D000077204:Temozolomide; D025521:Tumor Suppressor Proteins / Q000378:metabolism
D018906:Antineoplastic Agents, Alkylating; D019394:Ki-67 Antigen; D025521:Tumor Suppressor Proteins; D003606:Dacarbazine; D007986:Luteinizing Hormone; D015254:DNA Modification Methylases; C515491:MGMT protein, human; D045643:DNA Repair Enzymes; D000077204:Temozolomide